Recombinant KIR2DL2 (Lirilumab Biosimilar) 抗体
This anti-KIR2DL2 (Lirilumab Biosimilar) antibody is a Human 单克隆 antibody detecting KIR2DL2 (Lirilumab Biosimilar) in ELISA 和 WB. Suitable for 人.
Quick Overview for Recombinant KIR2DL2 (Lirilumab Biosimilar) 抗体 (ABIN7538062)
抗原
KIR2DL2 (Lirilumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
标记
This KIR2DL2 (Lirilumab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Lirilumab Biosimilar - Anti-KIRD2 subgroup mAb - Research Grade
-
产品特性
- Antibody Type: Human IgG1
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
亚型
- IgG
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- KIR2DL2 (Lirilumab Biosimilar)
-
背景
- Lirilumab is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research.
-
CAS-编号
- 1000676-41-4
抗原
-
You are here:
